Mirela Memic
Dentist, Oral and Maxillofacial Surgery Apo, AE Doctor of Dentistry
NPI 1700165883 CMS profile 554074
USA Dentac Bavaria, Unit 28038, Apo, AE 09112
General payments
$60
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Mirela Memic of Apo, AE is reported in the CMS Open Payments database as having received $60 across 1 general payment and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 10th percentile of Dentist, Oral and Maxillofacial Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $60 | 1 |
Beside peers
- Mirela Memic
- Dentist, Oral and Maxillofacial Surgery median
- Middle half of Dentist, Oral and Maxillofacial Surgery
- National median
In program year 2025, general payments to Mirela Memic were reported at $60. Among 3,834 Dentist, Oral and Maxillofacial Surgery profiles paid that year, the median was $150 and the middle half received between $56 and $423.
Show as a table
| Year | Mirela Memic | Dentist, Oral and Maxillofacial Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $142 | $50–$420 | $163 |
| 2020 | $0 | $96 | $36–$277 | $114 |
| 2021 | $0 | $138 | $45–$419 | $132 |
| 2022 | $0 | $144 | $48–$367 | $149 |
| 2023 | $0 | $153 | $55–$399 | $160 |
| 2024 | $0 | $152 | $50–$400 | $164 |
| 2025 | $60 | $150 | $56–$423 | $169 |
Breakdown
Prescribing to Medicare patients
Part D · data year 2024 · 7 drugsPart D claims
624
Drug cost
$2,048
Branded share of claims
35.9%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Amoxicillin | Generic | 204 | $607 | |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | Brand | 116 | $415 | |
| Ibuprofen | Generic | 148 | $387 | |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | Brand | 80 | $239 | |
| Clindamycin Hcl | Generic | 34 | $212 | |
| Acetaminophen-Codeine Acetaminophen With Codeine | Brand | 28 | $116 | |
| Ondansetron Hcl | Generic | 14 | $71 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 5,440 Part D prescribers listed as Oral Surgery (Dentist only); they describe a distribution and say nothing about conduct.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Dentist, Oral and Maxillofacial Surgery in Armed Forces Europe
Matthew Vanhoof
Dentist, Oral and Maxillofacial Surgery · Apo, AE
Thomas Woolf
Dentist, Oral and Maxillofacial Surgery · Apo, AE
Matthew Wilson
Dentist, Oral and Maxillofacial Surgery · Apo, AE
Bradley Aebi
Dentist, Oral and Maxillofacial Surgery · Apo, AE
Karen Keith
Dentist, Oral and Maxillofacial Surgery · Apo, AE
Stanley Thomas
Dentist, Oral and Maxillofacial Surgery · Apo, AE
Related records
Dentist, Oral and Maxillofacial Surgery in Armed Forces Europe
Practitioners in the same specialty and state, ranked by reported value.
All Dentist, Oral and Maxillofacial Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Armed Forces Europe
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.